(1.20%) 5 070.55 points
(0.69%) 38 504 points
(1.59%) 15 697 points
(1.79%) $83.37
(2.62%) $1.838
(-0.42%) $2 336.50
(0.43%) $27.36
(-1.15%) $920.55
(-0.44%) $0.934
(-0.69%) $10.91
(-0.80%) $0.803
(-0.15%) $93.27
@ $3.23
Issued: 9 Feb 2024 @ 14:14
Return: -28.68%
Previous signal: Feb 8 - 10:29
Previous signal:
Return: 1.20 %
Live Chart Being Loaded With Signals
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia...
Stats | |
---|---|
Today's Volume | 79 945.00 |
Average Volume | 279 404 |
Market Cap | 60.71M |
EPS | $-0.255 ( 2024-04-01 ) |
Next earnings date | ( $-0.230 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.58 |
ATR14 | $0.0210 (0.91%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-11 | Hsu Jason | Buy | 31 000 | Common Stock |
2023-12-08 | Hsu Jason | Buy | 25 000 | Common Stock |
2023-08-14 | Morris Gabriel S | Buy | 293 000 | Stock Options |
2023-08-14 | Rachman Ilya M | Buy | 293 000 | Stock Options |
2023-09-15 | Hsu Jason | Buy | 7 000 | Common Stock |
INSIDER POWER |
---|
99.99 |
Last 65 transactions |
Buy: 7 237 723 | Sell: 879 400 |
Volume Correlation
Immix Biopharma, Inc. Correlation
10 Most Positive Correlations | |
---|---|
MOMO | 0.931 |
NYMTP | 0.93 |
TOUR | 0.928 |
QFIN | 0.924 |
WB | 0.921 |
OM | 0.917 |
MLCO | 0.917 |
GGAL | 0.917 |
VBNK | 0.915 |
TELA | 0.91 |
10 Most Negative Correlations | |
---|---|
SWAV | -0.921 |
NVTSW | -0.914 |
USCB | -0.913 |
THTX | -0.904 |
LARK | -0.903 |
PCRX | -0.899 |
SNPX | -0.894 |
PIII | -0.894 |
GOSS | -0.894 |
BCAB | -0.892 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Immix Biopharma, Inc. Correlation - Currency/Commodity
Immix Biopharma, Inc. Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-5 468.00 (0.00 %) |
EPS: | $-0.890 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $-3 076.00 (0.00 %) |
EPS: | $-0.260 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-1 381.00 (0.00 %) |
EPS: | $-0.230 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-506.00 (0.00 %) |
EPS: | $-0.240 |
Financial Reports:
No articles found.
Immix Biopharma, Inc.
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120, a tissue-specific biologic for the treatment of ulcerative colitis and severe Crohn's disease. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. The company was incorporated in 2012 and is headquartered in Los Angeles, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators